GDF15 protein could improve diabetes treatments

Today I bring you exciting news of the scientific community that could have a significant impact on the way we treat diabetes.

A recent study led by the University of Barcelona and Ciberdem has discovered a new mechanism that could improve the efficiency of current diabetes.

The study focused on a protein called GDF15, which is at high levels in many diseases, including heart failure, cancer and fatty liver.

It turns out that obese patients also have high levels of this protein, but its operation may be altered, which can lead to resistance to GDF15.

The most exciting thing is that researchers discovered that the GDF15 factor inhibits glucose synthesis in the liver, which could be key to controlling blood glucose levels in people with type 2 diabetes.

In addition, protein action could also help reduce the presence of liver fibrosis, a disorder associated with greater mortality in patients with fatty liver disease.

These findings are promising and could open new ways for the treatment of diabetes and other metabolic diseases.

Remember that these are preliminary results and that more research is needed to confirm these findings and develop effective treatments based on them.

Greetings,

You think about what a team of 8 people from a university has achieved and you wonder that it could be done if governments and companies in the world really put this problem.Imagine only for a moment that all personnel, all the effort and all the money of NATO or NASA invested in healing the diseases of the human being.
Diabetes are eaten in a week, cancer in a month and aging (it is considered a sickness) in 2 quarters.
But we live in a world in which they deprive the benefits, margins, buyers and accounts in Switzerland.
No camel would come a dose of drugs that heals you from the dependency of having to buy more every day.